News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Jordi Remon: Adagrasib and pembrolizumab show impressive mPFS in KRAS G12C mutant NSCLC
Jordi Remon/X
Mar 28, 2025, 14:31

Jordi Remon: Adagrasib and pembrolizumab show impressive mPFS in KRAS G12C mutant NSCLC

Jordi Remon, Thoracic Oncologist at CIOCC Barcelona, shared a post on X:

“Adagrasib 400 mg and Pembrolizumab impressive mPFS in KRAS G12C mutant NSCLC and PDL1 >50% and good safety.

Better than IO or CT and IO alone. Good chem-free strategy for patients.

Await the ph3 trial.”

Jordi Remon: Adagrasib and pembrolizumab show impressive mPFS in KRAS G12C mutant NSCLC

More posts featuring Jordi Remon.

Adagrasib cancer ELCC2025 Jordi Remon NSCLC OncoDaily Oncology pembrolizumab
Special Coverage
Voices
Aug 25, 2025, 11:37
Emmanuella-Faith Amoako: Turning a Moment into a Mission for Pediatric Cancer Care in Ghana
Voices
Aug 25, 2025, 11:07
Miriam Mutebi: From Lab Bench to Bedside
Opinion
Aug 25, 2025, 10:40
Udhayvir Grewal Thanks Jen Riechek for Her Leadership in ASCO EO/AYA Community of Practice
Science
Aug 25, 2025, 09:45
Myeloma Paper of the Day, August 25th, Suggested by Robert Orlowski
Voices
Aug 25, 2025, 09:35
Abdu Adem Yesufe: SPHMMC LINAC Installation Is Complete - A Milestone for Patient Care
Techology
Aug 25, 2025, 09:21
Olivier Elemento: A New Paradigm for Data Interaction - Combining Voice and Augmented Reality
Voices
Aug 25, 2025, 09:09
Caryn Lerman: USC Norris Showcases Future Leaders in Cancer Research
Positive
Aug 25, 2025, 09:01
Joanna Metzner-Sadurski: Historic 50 Million Dollar Anonymous Gift to the Medical University of South Carolina
Voices
Aug 25, 2025, 08:49
Narjust Florez: Boston City Councilor Explores the EQUAL Lung Cancer Screening Study
Voices
Aug 25, 2025, 08:46
Vivek Subbiah: Health-Related Quality of Life in KRASG12C-Mutated Colorectal Cancer
Dialogues
Aug 25, 2025, 06:21
Balstilimab and Botensilimab insights with Dr Benjamin Shelchter - Latest MSS CRC Data from ESMO GI
Voices
Aug 24, 2025, 21:47
Pat Garcia-Gonzalez: One Year of Breast Cancer Program Success in Kenya